Early research (Phase 1)Study completedNCT00600964What this trial is testingA Phase I/II Study of GX15-070MS in Untreated CLLWho this might be right forChronic Lymphocytic Leukemia Gemin X 26
Testing effectiveness (Phase 2)Study completedNCT00784927What this trial is testingLenalidomide, Rituximab, Cyclophosphamide, and Dexamethasone in Treating Patients With Previously Untreated Low-Grade Non-Hodgkin LymphomaWho this might be right forLymphoma Mayo Clinic 36
Early research (Phase 1)Ended earlyNCT01644253What this trial is testingPhase 1b Safety and Efficacy Study of TRU-016Who this might be right forChronic Lymphocytic LeukemiaPeripheral T-cell Lymphoma Aptevo Therapeutics 87
Testing effectiveness (Phase 2)Study completedNCT00602459What this trial is testingFludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic LeukemiaWho this might be right forStage I Chronic Lymphocytic LeukemiaStage II Chronic Lymphocytic LeukemiaStage III Chronic Lymphocytic Leukemia+1 more National Cancer Institute (NCI) 418
Testing effectiveness (Phase 2)Study completedNCT00002547What this trial is testingChemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic Syndromes Barbara Ann Karmanos Cancer Institute 280
Testing effectiveness (Phase 2)Study completedNCT00003829What this trial is testingChemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic LeukemiaWho this might be right forLeukemia Alliance for Clinical Trials in Oncology 34
Testing effectiveness (Phase 2)Ended earlyNCT02258529What this trial is testingIdelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic LymphomaWho this might be right forFollicular LymphomaSmall Lymphocytic Lymphoma Gilead Sciences 10
Not applicableStudy completedNCT00934986What this trial is testingNatural Killer Cells Function in Patients With Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Institut Paoli-Calmettes 70
Large-scale testing (Phase 3)Looking for participantsNCT07277231What this trial is testingInvestigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia BeOne Medicines 500
Large-scale testing (Phase 3)Study completedNCT00750009What this trial is testingPersonalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical TrialWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more Case Comprehensive Cancer Center 583
Not applicableWithdrawnNCT00378781What this trial is testingHeparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related InfectionWho this might be right forCancer M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Active Not RecruitingNCT04075292What this trial is testingStudy of Acalabrutinib Versus Chlorambucil Plus Rituximab in Adult Subjects With Previously Untreated Chronic Lymphocytic LeukemiaWho this might be right forUntreated Chronic Lymphocytic Leukemia AstraZeneca 155
Testing effectiveness (Phase 2)Study completedNCT01563055What this trial is testingA Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic LeukemiaWho this might be right forLeukaemia, Lymphocytic, Chronic GlaxoSmithKline 10
Testing effectiveness (Phase 2)Looking for participantsNCT07014917What this trial is testingIntermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLLWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaCLL Variant Zulfa Omer 62
Testing effectiveness (Phase 2)Study completedNCT02315768What this trial is testingIbrutinib in Combination With GA101 (Obinutuzumab) in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients.Who this might be right forChronic Lymphocytic Leukemia University of California, San Diego 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT02158091What this trial is testingA Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLLWho this might be right forChronic Lymphocytic Leukemia Dana-Farber Cancer Institute 32
Early research (Phase 1)Study completedNCT00058227What this trial is testingAlvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell LymphomaWho this might be right forB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Grade 1 Follicular LymphomaContiguous Stage II Grade 2 Follicular Lymphoma+40 more National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Study completedNCT00027820What this trial is testingTotal-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerWho this might be right forAdult Acute Myeloid Leukemia in RemissionChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in Remission+27 more Fred Hutchinson Cancer Center 106
Testing effectiveness (Phase 2)Study completedNCT00098670What this trial is testingFludarabine, Rituximab, and Alemtuzumab in Treating Patients With Chronic Lymphocytic LeukemiaWho this might be right forB-cell Chronic Lymphocytic LeukemiaStage I Chronic Lymphocytic LeukemiaStage II Chronic Lymphocytic Leukemia+2 more National Cancer Institute (NCI) 102
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75